These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 25733584)

  • 1. Randomized phase 2 study of GMI-1070 in SCD: reduction in time to resolution of vaso-occlusive events and decreased opioid use.
    Telen MJ; Wun T; McCavit TL; De Castro LM; Krishnamurti L; Lanzkron S; Hsu LL; Smith WR; Rhee S; Magnani JL; Thackray H
    Blood; 2015 Apr; 125(17):2656-64. PubMed ID: 25733584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized clinical trial of the efficacy and safety of rivipansel for sickle cell vaso-occlusive crisis.
    Dampier CD; Telen MJ; Wun T; Brown RC; Desai P; El Rassi F; Fuh B; Kanter J; Pastore Y; Rothman J; Taylor JG; Readett D; Sivamurthy KM; Tammara B; Tseng LJ; Lozier JN; Thackray H; Magnani JL; Hassell KL;
    Blood; 2023 Jan; 141(2):168-179. PubMed ID: 35981565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Poloxamer 188 vs Placebo on Painful Vaso-Occlusive Episodes in Children and Adults With Sickle Cell Disease: A Randomized Clinical Trial.
    Casella JF; Barton BA; Kanter J; Black LV; Majumdar S; Inati A; Wali Y; Drachtman RA; Abboud MR; Kilinc Y; Fuh BR; Al-Khabori MK; Takemoto CM; Salman E; Sarnaik SA; Shah N; Morris CR; Keates-Baleeiro J; Raj A; Alvarez OA; Hsu LL; Thompson AA; Sisler IY; Pace BS; Noronha SA; Lasky JL; de Julian EC; Godder K; Thornburg CD; Kamberos NL; Nuss R; Marsh AM; Owen WC; Schaefer A; Tebbi CK; Chantrain CF; Cohen DE; Karakas Z; Piccone CM; George A; Fixler JM; Singleton TC; Moulton T; Quinn CT; de Castro Lobo CL; Almomen AM; Goyal-Khemka M; Maes P; Emanuele M; Gorney RT; Padgett CS; Parsley E; Kronsberg SS; Kato GJ; Gladwin MT
    JAMA; 2021 Apr; 325(15):1513-1523. PubMed ID: 33877274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of the DOVE (Determining Effects of Platelet Inhibition on Vaso-Occlusive Events) trial: A global Phase 3 double-blind, randomized, placebo-controlled, multicenter study of the efficacy and safety of prasugrel in pediatric patients with sickle cell anemia utilizing a dose titration strategy.
    Hoppe CC; Styles L; Heath LE; Zhou C; Jakubowski JA; Winters KJ; Brown PB; Rees DC; Heeney MM
    Pediatr Blood Cancer; 2016 Feb; 63(2):299-305. PubMed ID: 26402148
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase 1 study of the E-selectin inhibitor GMI 1070 in patients with sickle cell anemia.
    Wun T; Styles L; DeCastro L; Telen MJ; Kuypers F; Cheung A; Kramer W; Flanner H; Rhee S; Magnani JL; Thackray H
    PLoS One; 2014; 9(7):e101301. PubMed ID: 24988449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, controlled clinical trial of ketoprofen for sickle-cell disease vaso-occlusive crises in adults.
    Bartolucci P; El Murr T; Roudot-Thoraval F; Habibi A; Santin A; Renaud B; Noël V; Michel M; Bachir D; Galactéros F; Godeau B
    Blood; 2009 Oct; 114(18):3742-7. PubMed ID: 19717646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide for inhalation in the acute treatment of sickle cell pain crisis: a randomized controlled trial.
    Gladwin MT; Kato GJ; Weiner D; Onyekwere OC; Dampier C; Hsu L; Hagar RW; Howard T; Nuss R; Okam MM; Tremonti CK; Berman B; Villella A; Krishnamurti L; Lanzkron S; Castro O; Gordeuk VR; Coles WA; Peters-Lawrence M; Nichols J; Hall MK; Hildesheim M; Blackwelder WC; Baldassarre J; Casella JF;
    JAMA; 2011 Mar; 305(9):893-902. PubMed ID: 21364138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of crizanlizumab on pain crises in subgroups of patients with sickle cell disease: A SUSTAIN study analysis.
    Kutlar A; Kanter J; Liles DK; Alvarez OA; Cançado RD; Friedrisch JR; Knight-Madden JM; Bruederle A; Shi M; Zhu Z; Ataga KI
    Am J Hematol; 2019 Jan; 94(1):55-61. PubMed ID: 30295335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sevuparin for the treatment of acute pain crisis in patients with sickle cell disease: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
    Biemond BJ; Tombak A; Kilinc Y; Al-Khabori M; Abboud M; Nafea M; Inati A; Wali Y; Kristensen J; Kowalski J; Donnelly E; Ohd J;
    Lancet Haematol; 2021 May; 8(5):e334-e343. PubMed ID: 33894169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3).
    Heeney MM; Abboud MR; Amilon C; Andersson M; Githanga J; Inusa B; Kanter J; Leonsson-Zachrisson M; Michelson AD; Berggren AR;
    Contemp Clin Trials; 2019 Oct; 85():105835. PubMed ID: 31446143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-Dose Ketamine Infusion for Adjunct Management during Vaso-occlusive Episodes in Adults with Sickle Cell Disease: A Case Series.
    Palm N; Floroff C; Hassig TB; Boylan A; Kanter J
    J Pain Palliat Care Pharmacother; 2018 Mar; 32(1):20-26. PubMed ID: 29791238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 study.
    Heeney MM; Abboud MR; Githanga J; Inusa BPD; Kanter J; Michelson AD; Nduba V; Musiime V; Apte M; Inati A; Taksande AM; Andersson M; Åstrand M; Maklad N; Niazi M; Himmelmann A; Berggren AR
    Blood; 2022 Sep; 140(13):1470-1481. PubMed ID: 35849650
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sickle Cell Disease Treatment with Arginine Therapy (STArT): study protocol for a phase 3 randomized controlled trial.
    Rees CA; Brousseau DC; Cohen DM; Villella A; Dampier C; Brown K; Campbell A; Chumpitazi CE; Airewele G; Chang T; Denton C; Ellison A; Thompson A; Ahmad F; Bakshi N; Coleman KD; Leibovich S; Leake D; Hatabah D; Wilkinson H; Robinson M; Casper TC; Vichinsky E; Morris CR;
    Trials; 2023 Aug; 24(1):538. PubMed ID: 37587492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intranasal fentanyl for initial treatment of vaso-occlusive crisis in sickle cell disease.
    Fein DM; Avner JR; Scharbach K; Manwani D; Khine H
    Pediatr Blood Cancer; 2017 Jun; 64(6):. PubMed ID: 27862905
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso-occlusive Pain Crises in Patients with Sickle Cell Disease.
    Han J; Saraf SL; Gordeuk VR
    Pharmacotherapy; 2020 Jun; 40(6):535-543. PubMed ID: 32350885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IF IM in a crisis: Intranasal fentanyl versus intravenous morphine in adult vaso-occlusive crisis.
    Assad O; Zamora R; Brown K; Melnitsky L; Moses J; Sherman V
    Am J Emerg Med; 2023 Feb; 64():86-89. PubMed ID: 36481614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Multinational Trial of Prasugrel for Sickle Cell Vaso-Occlusive Events.
    Heeney MM; Hoppe CC; Abboud MR; Inusa B; Kanter J; Ogutu B; Brown PB; Heath LE; Jakubowski JA; Zhou C; Zamoryakhin D; Agbenyega T; Colombatti R; Hassab HM; Nduba VN; Oyieko JN; Robitaille N; Segbefia CI; Rees DC;
    N Engl J Med; 2016 Feb; 374(7):625-35. PubMed ID: 26644172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pain Control for Sickle Cell Crisis, a Novel Approach? A Retrospective Study.
    Rollé A; Vidal E; Laguette P; Garnier Y; Delta D; Martino F; Portecop P; Etienne-Julan M; Piednoir P; De Jong A; Romana M; Bernit E
    Medicina (Kaunas); 2023 Dec; 59(12):. PubMed ID: 38138299
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of poloxamer 188 treatment on sickle cell vaso-occlusive crisis: computer-assisted intravital microscopy study.
    Cheung AT; Chan MS; Ramanujam S; Rangaswami A; Curl K; Franklin P; Wun T
    J Investig Med; 2004 Sep; 52(6):402-6. PubMed ID: 15612454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crizanlizumab for the Prevention of Pain Crises in Sickle Cell Disease.
    Ataga KI; Kutlar A; Kanter J; Liles D; Cancado R; Friedrisch J; Guthrie TH; Knight-Madden J; Alvarez OA; Gordeuk VR; Gualandro S; Colella MP; Smith WR; Rollins SA; Stocker JW; Rother RP
    N Engl J Med; 2017 Feb; 376(5):429-439. PubMed ID: 27959701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.